BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines-Reference-Cited by-同舟云学术

BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines

Published:2017-09 Issue: Volume:404 Page:70-78
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Borst Andreas,Haferkamp Sebastian,Grimm Johannes,Rösch Manuel,Zhu Guannan,Guo Sen,Li Chunying,Gao Tianwen,Meierjohann Svenja,Schrama David,Houben Roland^ORCID

Funder

Interdisziplinäres Zentrum für Klinische Forschung Würzburg

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Genomic classification of cutaneous melanoma;Cell,2015

2. Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy;Eroglu;Ther. Adv. Med. Oncol.,2016

3. Updates in therapy for advanced melanoma;Singh;Cancers,2016

4. Vemurafenib induces senescence features in melanoma cells;Haferkamp;J. Invest Dermatol,2013

5. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models;Yang;Cancer Res.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils;Cancers;2024-05-02

2. Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation;Molecular Cancer;2024-04-20

3. Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD- 1/PD-L1 axis blockade via Id1 downregulation;2023-08-18

4. Sestrin2 contributes to BRAF inhibitor resistance via reducing redox vulnerability of melanoma cells;Journal of Dermatological Science;2023-02

5. Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma;Biomolecules;2022-10-26